U.S. Veterinary Medicine Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals, Medicated Feed Additives), By Animal Type (Production, Companion), By Route Of Administration, By Distribution Channel, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased Database
                        1.3.2. GVR’s Internal Database
                        1.3.3. Secondary Sources
                        1.3.4. Primary Research
                        1.3.5. Details of Primary Research
                        1.3.6. Data analysis model
                    1.4. Information/Data Analysis
                    1.5. Market Formulation & Visualization
                    1.6. Data Validation & Publishing
                    1.7. Model Details
                        1.7.1. Commodity flow analysis
                        1.7.2. Market: CAGR Calculation
                    1.8. List of Secondary Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Veterinary Medicine Market Variable Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market
                        3.1.2. Ancillary Market
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Increasing prevalence of chronic disease in pets
                            3.2.1.2. Rising pet expenditure and pet humanization
                            3.2.1.3. Technological advancements
                            3.2.1.4. Strategic initiatives by key players
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Stringent regulatory process
                            3.2.2.2. Increasing Influx Of Counterfeit Drugs.
                        3.2.3. Market Opportunity Analysis
                        3.2.4. Market Challenge Analysis
                    3.3. U.S. Veterinary Medicine Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitution
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Legal landscape
                            3.3.2.3. Economic landscape
                            3.3.2.4. Social landscape
                            3.3.2.5. Technological landscape
                            3.3.2.6. Environmental landscape
                    3.4. Pricing Analysis
                    3.5. Regulatory Framework
                    3.6. Product Pipeline Analysis
                    3.7. Estimated Animal Population by key Species, 2021 - 2024
Chapter 4. U.S. Veterinary Medicine Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Veterinary Medicine Market: Product Movement Analysis
                    4.3. U.S. Veterinary Medicine Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
                    4.4. Biologics
                        4.4.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.4.2. Vaccines
                            4.4.2.1. Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                            4.4.2.2. Modified/ Attenuated
                                4.4.2.2.1. Modified/ Attenuated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                            4.4.2.3. Inactivated (Killed)
                                4.4.2.3.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                            4.4.2.4. Other Vaccines
                                4.4.2.4.1. Other Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.4.3. Other Biologics
                            4.4.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.5. Pharmaceuticals
                        4.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.2. Parasiticides
                            4.5.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.3. Anti-Infectives
                            4.5.3.1. Anti-Infectives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.4. Anti-Inflammatory
                            4.5.4.1. Anti-Inflammatory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.5. Analgesics
                            4.5.5.1. Analgesics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        4.5.6. Others
                            4.5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.6. Medicated Feed Additives
                        4.6.1. Medicated Feed Additives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.7. Others
Chapter 5. U.S. Veterinary Medicine Market: Animal Type Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Veterinary Medicine Market: Animal Type Movement Analysis
                    5.3. U.S. Veterinary Medicine Market Size & Trend Analysis, by Animal Type, 2021 to 2033 (USD Million)
                    5.4. Production Animals
                        5.4.1. Production Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.4.2. Poultry
                            5.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.4.3. Pigs
                            5.4.3.1. Pigs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.4.4. Cattle
                            5.4.4.1. Cattle Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.4.5. Sheep & Goat
                            5.4.5.1. Sheep & goat Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.4.6. Others
                            5.4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.5. Companion Animals
                        5.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.5.2. Dogs
                            5.5.2.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.5.3. Cats
                            5.5.3.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.5.4. Horses
                            5.5.4.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.5.5. Others
                            5.5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Veterinary Medicine Market: Route of Administration Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Veterinary Medicine Market: Route of Administration Movement Analysis
                    6.3. U.S. Veterinary Medicine Market Size & Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
                    6.4. Oral
                        6.4.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.4.2. Injectable
                        6.4.3. Injectable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.4.4. Topical
                        6.4.5. Topical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.5. Others
                        6.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Veterinary Medicine Market: By Distribution Channel Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Veterinary Medicine Market: By End Use Movement Analysis
                    7.3. U.S. Veterinary Medicine Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                        7.3.1. Veterinary Clinics & Hospitals
                            7.3.1.1. Veterinary Clinics & Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.3.2. E-Commerce
                            7.3.2.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.3.3. Offline Retail Stores
                            7.3.3.1. Offline Retail Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                        7.3.4. Others
                            7.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Market Participant Categorization
                    8.2. Company Market Position Analysis/ Heat Map Analysis
                    8.3. Company Market Share Analysis, 2024
                    8.4. Company Profiles
                        8.4.1. Boehringer Ingelheim International GmbH
                            8.4.1.1. Participant’s Overview
                            8.4.1.2. Financial Performance
                            8.4.1.3. Product/Service Benchmarking
                            8.4.1.4. Strategic Initiatives
                        8.4.2. Zoetis
                            8.4.2.1. Participant’s Overview
                            8.4.2.2. Financial Performance
                            8.4.2.3. Product/Service Benchmarking
                            8.4.2.4. Strategic Initiatives
                        8.4.3. Merck & Co., Inc.
                            8.4.3.1. Participant’s Overview
                            8.4.3.2. Financial Performance
                            8.4.3.3. Product/Service Benchmarking
                            8.4.3.4. Strategic Initiatives
                        8.4.4. Elanco
                            8.4.4.1. Participant’s Overview
                            8.4.4.2. Financial Performance
                            8.4.4.3. Product/Service Benchmarking
                            8.4.4.4. Strategic Initiatives
                        8.4.5. Dechra Pharmaceuticals PLC
                            8.4.5.1. Participant’s Overview
                            8.4.5.2. Financial Performance
                            8.4.5.3. Product/Service Benchmarking
                            8.4.5.4. Strategic Initiatives
                        8.4.6. Ceva Santé Animale
                            8.4.6.1. Participant’s Overview
                            8.4.6.2. Financial Performance
                            8.4.6.3. Product/Service Benchmarking
                            8.4.6.4. Strategic Initiatives
                        8.4.7. Bimeda Corporate
                            8.4.7.1. Participant’s Overview
                            8.4.7.2. Financial Performance
                            8.4.7.3. Product/Service Benchmarking
                            8.4.7.4. Strategic Initiatives
                        8.4.8. Biogénesis Bagó
                            8.4.8.1. Participant’s Overview
                            8.4.8.2. Financial Performance
                            8.4.8.3. Product/Service Benchmarking
                            8.4.8.4. Strategic Initiatives
                        8.4.9. Phibro Animal Health Corporation
                            8.4.9.1. Participant’s Overview
                            8.4.9.2. Financial Performance
                            8.4.9.3. Product/Service Benchmarking
                            8.4.9.4. Strategic Initiatives
                        8.4.10. Virbac
                            8.4.10.1. Participant’s Overview
                            8.4.10.2. Financial Performance
                            8.4.10.3. Product/Service Benchmarking
                            8.4.10.4. Strategic Initiatives
                    8.5. Strategy Mapping
                        8.5.1. Mergers & Acquisitions
                        8.5.2. Partnerships & Collaborations
                        8.5.3. Product/Service launch
                        8.5.4. Others
                    8.6. List of other key players

List of Tables

Table 1 List Of Secondary Sources
Table 2 U.S. Veterinary Medicine Market, By Product, 2021 - 2033 (USD Million)
Table 3 U.S. Veterinary Medicine Market, By Animal Type, 2021 - 2033 (USD Million)
Table 4 U.S. Veterinary Medicine Market, By Route of Administration, 2021 - 2033 (USD Million)
Table 5 U.S. Veterinary Medicine Market, By Distribution Channel, 2021 - 2033 (USD Million)
Table 6 Company Overview
Table 7 Product Benchmarking
Table 8 Financial Performance
Table 9 Strategic Initiatives

List of Figures

Fig. 1 Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Information Procurement
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value Chain-Based Sizing & Forecasting
Fig. 7 QFD Modelling For Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 U.S. Veterinary Medicine Market Revenue, 2021 - 2033 (USD Million)
Fig. 10 U.S. Veterinary Medicine Market Snapshot
Fig. 11 U.S. Veterinary Medicine Market Driver Impact
Fig. 12 U.S. Veterinary Medicine Market Restraint Impact
Fig. 13 U.S. Veterinary Medicine Product Key Takeaways (USD Million)
Fig. 14 U.S. Veterinary Medicine Market: Product, Market Share 2024 & 2033
Fig. 15 Biologics Market, 2021 - 2033 (USD Million)
Fig. 16 Vaccines Market, 2021 - 2033 (USD Million)
Fig. 17 Modified/ Attenuated Live Market, 2021 - 2033 (USD Million)
Fig. 18 Inactivated (Killed) Market, 2021 - 2033 (USD Million)
Fig. 19 Other Vaccines Market, 2021 - 2033 (USD Million)
Fig. 20 Other Biologics Market, 2021 - 2033 (USD Million)
Fig. 21 Medicated Feed Additives Market, 2021 - 2033 (USD Million)
Fig. 22 Pharmaceuticals Market, 2021 - 2033 (USD Million)
Fig. 23 Parasiticides Market, 2021 - 2033 (USD Million)
Fig. 24 Anti-infectives Market, 2021 - 2033 (USD Million)
Fig. 25 Anti-inflammatory Market, 2021 - 2033 (USD Million)
Fig. 26 Analgesic Market, 2021 - 2033 (USD Million)
Fig. 27 Other Vaccines Market, 2021 - 2033 (USD Million)
Fig. 28 U.S. Veterinary Medicine Animal Type Key Takeaways (USD Million)
Fig. 29 U.S. Veterinary Medicine Market: Animal Type, Market Share 2024 & 2033
Fig. 30 Production Animals Market, 2021 - 2033 (USD Million)
Fig. 31 Poultry Animals Market, 2021 - 2033 (USD Million)
Fig. 32 Pigs Animals Market, 2021 - 2033 (USD Million)
Fig. 33 Cattle Animals Market, 2021 - 2033 (USD Million)
Fig. 34 Sheep & Goat Animals Market, 2021 - 2033 (USD Million)
Fig. 35 Others Market, 2021 - 2033 (USD Million)
Fig. 36 Companion Animals Market, 2021 - 2033 (USD Million)
Fig. 37 Dogs Animals Market, 2021 - 2033 (USD Million)
Fig. 38 Cats Animals Market, 2021 - 2033 (USD Million)
Fig. 39 Horses Animals Market, 2021 - 2033 (USD Million)
Fig. 40 Others Market, 2021 - 2033 (USD Million)
Fig. 41 U.S. Veterinary Medicine Route of Administration Key Takeaways (USD Million)
Fig. 42 U.S. Veterinary Medicine Market: Route of Administration, Market Share 2024 & 2033
Fig. 43 Oral Market, 2021 - 2033 (USD Million)
Fig. 44 Injectable Market, 2021 - 2033 (USD Million)
Fig. 45 Topical Market, 2021 - 2033 (USD Million)
Fig. 46 Others Market, 2021 - 2033 (USD Million)
Fig. 47 U.S. Veterinary Medicine Market By End Use: Key Takeaways
Fig. 48 U.S. Veterinary Medicine Market By End Use, Market Share, 2024 & 2033
Fig. 49 Veterinary Clinics & Hospitals Market, 2021 - 2033 (USD Million)
Fig. 50 E-Commerce Market, 2021 - 2033 (USD Million)
Fig. 51 Offline Retail Stores Market, 2021 - 2033 (USD Million)
Fig. 52 Others Market, 2021 - 2033 (USD Million)
Fig. 53 Market Participant Categorization
Fig. 54 Market Share Of Key Market Players U.S. Veterinary Medicine Market